SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AstraZeneca - Enters Exclusive Global License Agreement For Zegfrovy With Dizal Pharmaceutical

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.